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PURPOSE. To examine the cross-sectional relationship of the
metabolic syndrome (hypertension, hyperglycemia, central
obesity, and dyslipidemia) and retinal microvascular abnormal-
ities in middle-aged men and women.
METHODS. A population-based, cross-sectional study involving
11,265 persons aged 49 to 73 years who had retinal photogra-
phy from 1993 through 1995. Photographs were graded for
presence of retinal microvascular signs (microaneurysms, reti-
nal hemorrhages, arteriovenous nicking, and focal arteriolar
narrowing) according to a standardized protocol. To quantify
retinal vessel diameters, photographs were digitized and indi-
vidual arteriolar and venular diameters were measured and
summarized. The metabolic syndrome was defined according
to the Third Report of the National Cholesterol Education
Program Adult Treatment Panel.
RESULTS. After adjustment for age, gender, race, education,
cigarette smoking and alcohol consumption, persons with the
metabolic syndrome were more likely to have retinopathy
(odds ratio [OR] 1.68, 95% confidence interval [CI], 1.45–
1.96), arteriovenous nicking (OR 1.30, 95% CI, 1.16–1.45),
focal arteriolar narrowing (OR 1.24, 95% CI, 1.10–1.38), gen-
eralized retinal arteriolar narrowing (OR 1.23, 95% CI, 1.12–
1.35), and generalized retinal venular dilatation (OR 1.30, 95%
CI, 1.18–1.48) than persons without the metabolic syndrome.
Associations for arteriovenous nicking, focal arteriolar narrow-
ing, generalized arteriolar narrowing, and venular dilatation
were noted, even in people without diabetes or hypertension.
CONCLUSIONS. These data suggest that the metabolic syndrome
is associated with microvascular changes in the retina. This
finding reflects, in part, the associations of individual syndrome
components with retinal microvascular abnormalities. (Invest
Ophthalmol Vis Sci. 2004;45:2949–2954) DOI:10.1167/
iovs.04-0069
The metabolic syndrome consists of a clustering of diseases,including central obesity, dyslipidemia, hyperglycemia,
and high blood pressure. The syndrome is increasingly recog-
nized as being a distinct entity affecting a large proportion of
the U.S. adult population.1,2 Persons with the metabolic syn-
drome are at known risk of development of large-vessel ath-
erosclerotic diseases.3,4 It is unclear, however, whether the
metabolic syndrome is associated with microvascular dis-
ease.5–7 Characteristics of large and small vessel disease, such
as inflammation and endothelial dysfunction, have been re-
ported to be associated with the metabolic syndrome in some,
but not all, studies.8–12
The associations of diabetes and hypertension with retinop-
athy and other microvascular changes (e.g., retinal arteriolar
narrowing and arteriovenous nicking) are well known.13 Re-
cent studies have shown that these retinal microvascular signs
are also associated with systemic markers of inflammation and
endothelial dysfunction,14 and incidence of diabetes and hy-
pertension.15,16 However, the relationship of the metabolic
syndrome and retinal microvascular signs has not been evalu-
ated.
In the present study, we examined the cross-sectional asso-
ciation of the metabolic syndrome and retinal microvascular
signs in a large population of middle-aged men and women.
METHODS
Study Population
The Atherosclerosis Risk In Communities (ARIC) study is a population-
based cohort study that included 15,792 women and men 45 to 64
years of age at recruitment from 1987 through 1989.17 Population
samples were selected from four U.S. communities: Forsyth County,
North Carolina; Jackson, Mississippi (blacks only); suburbs of Minne-
apolis, Minnesota; and Washington County, Maryland.17 Of those ex-
amined at baseline, 86.2% returned for the third examination 6 years
from baseline (1993–1995).
All data are based on the third examination, when retinal photog-
raphy was first performed.18 Of the 12,887 who returned for this
examination, we excluded 271 with retinal vascular occlusions, 738
with ungradable photographs, 477 without fasting (8 hours) glucose
levels, and 56 with missing data on a component of the metabolic
syndrome and, due to small numbers, 38 whose race was neither black
nor white and 42 black residents in Minneapolis and Maryland, leaving
11,265 who provided data for the present study. Characteristics of
participants with and without gradable retinal photographs have been
reported.18 Individuals with gradable photographs were younger and
more likely to be white, but did not differ from participants with
ungradable photographs on gender or smoking status.
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Institutional review boards at each study site and at the Fundus
Photograph Reading Center at the University of Wisconsin, Madison,
approved the study. Informed consent was obtained from all partici-
pants and the study was conducted in accordance with the Declaration
of Helsinki.
Definition of the Metabolic Syndrome
Anthropometrics were taken with the subject wearing a scrub suit and
no shoes.19 Waist circumference was measured at the umbilicus (in
centimeters). Participants were asked to fast for at least 8 hours before
morning blood collection. Blood was drawn from the antecubital vein
of seated participants and serum and plasma aliquots were frozen at
70°C and shipped to central laboratories for analysis.20 Triglycerides,
high-density lipoprotein (HDL) cholesterol, and glucose were assayed
according to ARIC Study protocols.19,20 Blood pressure was measured
three times using a random-0 sphygmomanometer.9,16
We defined the metabolic syndrome according to criteria by the
Third Report of the National Cholesterol Education Program Adult
Treatment Panel (ATP III),21 which include three or more of the
following five components:
1. Waist circumference greater than 102 cm in men and 88 cm in
women (defined as having a large waist in the present study)
2. Serum triglyceride level of at least 150 mg/dL (1.69 mM) (de-
fined as having hypertriglyceridemia)
3. HDL-cholesterol level of less than 40 mg/dL (1.04 mM) in men
and 50 mg/dL (1.29 mM) in women (defined as having low
HDL-cholesterol)
4. Systolic blood pressure of at least 130 mm Hg or diastolic blood
pressure of at least 85 mm Hg (defined as having high blood
pressure)
5. Fasting (8 hours in the ARIC study) glucose level of at least
110 mg/dL (6.1 mM; defined as having high glucose).
Individuals also met the criteria for high blood pressure and high
fasting glucose if they reported taking medication for hypertension or
diabetes, respectively, or if, in the case of diabetes, they reported a
physician’s diagnosis of the condition.
For the purpose of subgroup analyses, diabetes was defined as
fasting serum glucose levels of at least 126 mg/dL (7.0 mM), diabetic
medication use or a physician’s diagnosis of diabetes, and hypertension
was defined as systolic blood pressure of at least 140 mm Hg, a diastolic
blood pressure of at least 90 mm Hg, or use of antihypertensive
medication during the previous 2 weeks.
Retinal Photography and Definitions
The retinal photography procedure and grading of retinal microvascu-
lar signs have been described in detail elsewhere.14–16,18 Briefly, retinal
photography of one randomly selected eye of each participant was
taken at the third examination. If the eye selected randomly was
considered too difficult or not possible to photograph with adequate
quality (e.g., inability to dilate to at least 4 mm, inability to fixate
adequately for proper photographic field definition, or opacities of the
ocular media preventing a reasonably clear view of the retina), the
fellow eye was photographed instead. After 5 minutes of dark adapta-
tion, a 45° photograph was taken, centered on the region of the optic
disc and the macula, with an autofocus camera.
Trained graders, masked to participant characteristics, examined
the photographs for the presence of discrete retinal microvascular
abnormalities, including retinopathy (e.g., microaneurysms, retinal
hemorrhages and soft exudates), arteriovenous nicking, and focal ar-
teriolar narrowing. The grading and definition of these lesions were
based on a standard protocol described in other reports.18 To quantify
retinal arteriolar and venular diameters, the fundus photographs were
digitized, and the diameters of all arterioles and venules coursing
through a specified area surrounding the optic disc were measured by
using a computer-assisted approach. Individual vessel diameters were
combined into summary measures of arteriolar and venular diameters
of the eye, based on previously published formulas.18,22 Generalized
arteriolar narrowing was defined as the lowest quintile (smallest
20%) of the population distribution of arteriolar diameters, and the
higher four quintiles were defined as no arteriolar narrowing. Gen-
eralized venular dilatation was defined as the highest quintile (larg-
est 20%) of the venular diameters, and the four lower quintiles were
defined as no dilatation. Quality control procedures are described
elsewhere.18
Statistical Analysis
The metabolic syndrome was categorized as present versus absent.
Individual components of the syndrome were also analyzed separately.
All retinal microvascular signs (retinopathy, arteriovenous nicking,
focal arteriolar narrowing, generalized arteriolar narrowing, and gen-
eralized venular dilatation) were defined as binary variables.
Logistic regression was used to determine the odds ratios of various
retinal microvascular signs, comparing the presence versus absence of
the metabolic syndrome. All models were initially adjusted for age,
gender, race, and field center. Because both the metabolic syndrome
and retinal signs were associated with educational levels, cigarette
smoking, and alcohol consumption status,1,2,13 these were included in
the final models as additional independent variables.
Finally, to examine the independent association between a specific
metabolic syndrome component and retinal microvascular signs, logis-
tic regression models of retinal microvascular signs were constructed
with metabolic syndrome components entered simultaneously as in-















n % n % n % n % n %
Metabolic Syndrome Present 4221 8.8 4144 16.4 4062 17.2 3907 27.5 1072 27.4
Absent 7041 5.1 6929 12.8 6807 13.5 6552 23.6 1534 23.4
Syndrome Components
Large waist Present 6807 7.1 6694 15.3 6574 15.9 6317 25.9 6317 25.6
Absent 4455 5.7 4379 12.4 4295 15.3 4142 23.7 4142 23.9
High triglyceride Present 4123 7.3 4057 14.3 3971 15.1 3837 23.8 3837 27.4
Absent 7139 6.1 7016 14.0 6898 14.8 6622 25.7 6622 23.5
Low HDL cholesterol Present 3830 6.9 3768 15.5 3689 15.3 3573 26.8 3573 25.3
Absent 7432 6.3 7305 13.4 7180 14.7 6886 24.2 6886 24.7
High blood pressure Present 6032 8.1 5925 16.5 5793 19.9 5537 31.2 5537 25.2
Absent 5230 4.7 5148 11.3 5076 9.2 4922 18.1 4922 24.6
High glucose Present 2932 11.8 2861 15.8 2808 15.6 2701 25.5 2701 30.2
Absent 8330 4.7 8212 13.5 8061 14.6 7758 24.9 7758 23.1
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dependent variables, adjusting for age, gender, race, field center, edu-
cation, cigarette smoking, and alcohol consumption.
RESULTS
In the study population, the mean age of participants was
59.8  5.6 years, and 55.8% were female, 20.8% were African-
American, 80.8% had completed high school, 58.7% had a
history of cigarette smoking, and 75.6% a history of alcohol
consumption.
Table 1 shows the prevalence of retinal microvascular signs
among participants with and without the metabolic syndrome
and its components. In general, the metabolic syndrome and
specific syndrome components were associated with a higher
prevalence of retinal microvascular signs.
Logistic regression models of retinal microvascular signs in
association with the metabolic syndrome are shown in Table 2.
After controlling for age, gender, race, field center, education,
cigarette smoking, and alcohol consumption status, partici-
pants with the metabolic syndrome were more likely to have
retinopathy, arteriovenous nicking, focal arteriolar narrowing,
generalized retinal arteriolar narrowing, and venular dilatation
than those without the syndrome. The pattern of association
was not substantially different, excluding people with diabe-
tes, hypertension, or both diabetes and hypertension, with the
exception that the association with retinopathy was no longer
significant in those without diabetes or hypertension.
Figure 1 shows that, after adjustment, the prevalence of
each retinal microvascular sign was higher with the increasing
number of syndrome components. For example, in the total
population, the prevalence of retinopathy increased from 5.3%
(no component) to 14.4% (five components) and in people
without diabetes or hypertension, the prevalence increased
from 4.6% (no component) to 10.4% (five components).
Finally, we examined the independent association between
specific components of the metabolic syndrome and retinal
microvascular signs (Table 3). Each model includes the five
syndrome components, and age, gender, race, field center,
education, smoking, and alcohol consumption as independent
variables. There were independent association between high
blood pressure and high glucose for retinopathy; between
larger waist circumference, low HDL-cholesterol, and high
blood pressure for arteriovenous nicking; between larger waist
circumference and high blood pressure for focal arteriolar
narrowing; between larger waist circumference, lower triglyc-
eride, higher blood pressure, and lower glucose for generalized
arteriolar narrowing; and between larger waist circumference,
higher triglyceride, and higher glucose for generalized venular
dilatation.
DISCUSSION
The National Cholesterol Education Program’s ATP III report
identified the metabolic syndrome as a specific entity deserving
more clinical attention.21 People with the syndrome have been
shown to be at increased risk of developing cardiovascular
disease, beyond the risk associated with individual compo-
nents of the syndrome alone.21 Our previous analyses focused
on the association of hypertension, diabetes, and other cardio-
vascular risk factors with retinal microvascular signs.14–16 The
present study extended these investigations by addressing the
relationship of the metabolic syndrome and retinal microvas-
cular signs.
We showed that persons with the metabolic syndrome
were significantly more likely to have retinopathy, arterio-
venous nicking, focal arteriolar narrowing, smaller retinal arte-
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people without the syndrome, independent of age, gender,
race, education, cigarette smoking, and alcohol consumption.
With the exception of retinopathy, most associations were
significant even in people without diabetes or hypertension,
suggesting that factors other than hyperglycemia and high
blood pressure (i.e., dyslipidemia, obesity, and inflammation)
may explain the occurrence of these retinal lesions. The asso-
ciation of the metabolic syndrome with retinal microvascular
abnormalities may in part reflect the impact of these individual
syndrome components on the presence of these retinal lesions.
Although this study was cross-sectional, the findings pro-
vide support to both experimental and clinical studies that
have suggested that microvascular disease may be an integral
component of the metabolic syndrome.5–7 For example, ex-
perimental studies have shown that Zucker rats, which exhibit
obesity, diabetes, and other elements of the metabolic syn-
FIGURE 1. Prevalence of retinal mi-
crovascular signs according to num-
ber of metabolic syndrome compo-
nents (0–5), adjusted for age,
gender, race, center, education,
smoking, and alcohol consumption.
Total population (top) and partici-
pants without diabetes or hyperten-
sion (bottom).

















OR (95% CI)* OR (95% CI)* OR (95% CI)* OR (95% CI)* OR (95% CI)*
Large waist Present vs. absent 0.99 (0.77, 1.10) 1.28 (1.13, 1.44) 1.14 (1.00, 1.29) 1.16 (1.05, 1.29) 1.14 (1.03, 1.27)
High triglyceride Present vs. absent 1.03 (0.87, 1.22) 0.90 (0.79, 1.01) 0.97 (0.86, 1.10) 0.83 (0.74, 0.92) 1.13 (1.02, 1.26)
Low HDL cholesterol Present vs. absent 1.01 (0.85, 1.21) 1.17 (1.04, 1.33) 0.91 (0.81, 1.04) 1.05 (0.95, 1.17) 1.05 (0.94, 1.17)
High blood pressure Present vs. absent 1.31 (1.10, 1.55) 1.37 (1.22, 1.54) 2.34 (2.07, 2.64) 2.11 (1.92, 2.33) 0.94 (0.85, 1.03)
High glucose Present vs. absent 2.41 (2.05, 2.84) 0.99 (0.88, 1.13) 0.88 (0.77, 1.00) 0.89 (0.79, 0.99) 1.31 (1.18, 1.46)
* Each logistic regression model includes the retinal microvascular sign as the dependent variable and the five metabolic syndrome
components (large waist, high triglyceride, low HDL cholesterol, high blood pressure, high glucose, as defined in Table 1), age, gender, race, field
center, education, cigarette smoking, and alcohol consumption as independent variables.
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drome, have narrowed skeletal muscle arterioles and impaired
arteriolar reactivity to vasoactive stimuli.23 Clinical studies
have also documented alterations in the structure and function
of the microcirculation in skin and skeletal muscles of persons
with the metabolic syndrome,5–7 or with specific components
of the syndrome, including persons with type 2 diabetes,24
abdominal obesity,25 dyslipidemia, and hypertension.7–9,26
Studies by Serne et al.6,7and others5 show that patients with
insulin resistance have reduced capillary density and impaired
capillary recruitment and acetylcholine-mediated vasodilata-
tion in their skin. Most of these studies, however, have been
conducted on small numbers of highly selected individuals.
The present study provides evidence linking the metabolic
syndrome to retinal microvascular disease in a large general
population. However, it is difficult to determine from cross-
sectional findings whether microvascular processes (evident in
the retina) are causally related to development of the metabolic
syndrome, or whether the metabolic syndrome is associated
with risk of retinal microvascular signs.
A more detailed examination of the association of the met-
abolic syndrome with specific retinal microvascular abnormal-
ity reveals additional information. Retinopathy, defined to in-
clude microaneurysms, retinal hemorrhages, and soft exudates,
is a well-known complication of diabetes and hypertension and
is pathologically associated with a breakdown of the blood–
retinal barrier.13 In our study, after adjustment for other syn-
drome components, higher blood pressure, and fasting glu-
cose, but not larger waist circumference, higher triglyceride,
and lower HDL-cholesterol were associated with retinopathy
(Table 3). In addition, the association with retinopathy was no
longer present in people without diabetes or hypertension
(Table 2). These observations further support the concept that
retinopathy is related to factors associated with hyperglycemia
and elevated blood pressure.
In contrast to retinopathy, the independent associations of
the metabolic syndrome with other retinal microvascular signs
are more difficult to understand, partly because less is known
regarding the pathogenesis of these retinal characteristics.
Generalized retinal arteriolar narrowing is believed to result
from a combination of “active” vasomotor constriction and,
with increasing age, more generalized arteriolosclerosis (e.g.,
intimal thickening, medial hyperplasia, hyalinization, and scle-
rosis).13 Focal arteriolar narrowing may represent segmental
areas of arteriolar constriction and sclerosis, whereas arterio-
venous nicking may represent evidence of arteriolosclerotic
processes at the crossing of arterioles and venules.13 All three
arteriolar abnormalities are strongly related to hyperten-
sion.18,22 In the ARIC study, independent of blood pressure,
generalized arteriolar narrowing was also related to systemic
markers of inflammation, whereas arteriovenous nicking was
related to markers of inflammation and endothelial dysfunc-
tion.14 In people with diabetes, wider retinal venular diameters
have been suggested to reflect hyperperfusion resulting from
hyperglycemia and lactic acidosis from retinal hypoxia.27,28 In
the Wisconsin Epidemiologic Study of Diabetic Retinopathy,
retinal venular dilatation was associated with increased dura-
tion of diabetes, elevated glycosylated hemoglobin level and
higher body mass index,29 and predicted the incidence of gross
proteinuria and renal dysfunction.30 Taken together, these
findings suggest that microvascular processes associated with
inflammation, endothelial dysfunction, alterations in perfusion,
and other processes may explain the occurrence of these
retinal signs in persons with the metabolic syndrome.
In analyses of the associations with specific metabolic com-
ponents, there were some unexpected findings (Table 3). For
example, lower triglyceride and glucose levels were associated
with generalized arteriolar narrowing, findings for which we
have no explanation. A possible explanation is that, given the
common causality of syndrome elements, simultaneous mod-
eling of all the elements as independent variables may have
produced overadjustment.
The strengths of the present study include a large sample
size with participants drawn from the general population
rather than a clinic, the objective documentation of retinal
microvascular signs, and the standardized identification of met-
abolic syndrome components. Study limitations should also be
highlighted. First, these associations are cross-sectional, and
prospective data are needed to evaluate the causal link be-
tween the metabolic syndrome and the risk of retinopathy and
other microvascular changes. Second, our study used a 45°
nonstereoscopic fundus photograph taken through nonphar-
macologically dilated pupils to determine the presence of ret-
inal microvascular signs. These signs are less likely to be de-
tected than in grading of 30° stereoscopic fundus photographs
taken through dilated pupils. In addition, because only one eye
was photographed in the ARIC study, a proportion of people
with retinal microvascular signs may be missed because of the
possibility of the involved eye’s not being photographed. How-
ever, we have no reasons to believe these would substantially
bias the associations reported herein.
In conclusion, we documented cross-sectional associations
of the metabolic syndrome with retinal microvascular signs. To
a certain extent, these associations are manifestations of the
individual effects of various components of the metabolic syn-
drome—in particular, hypertension and diabetes—on the pres-
ence of retinal microvascular abnormalities. Prospective stud-
ies will be useful in further determinig whether the metabolic
syndrome is associated with an increased risk of retinopathy
and other retinal microvascular abnormalities, beyond the ef-
fects of individual components.
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